赛托生物(300583.SZ)：暂无直接生产适用于COPD的制剂

Group 1 - The company produces key starting materials for common COPD (Chronic Obstructive Pulmonary Disease) treatments, including dehydroepiandrosterone, betamethasone, and indacaterol maleate [1] - The company does not currently produce formulations specifically for COPD [1]